BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 12145953)

  • 21. Monitoring HIV through sentinel surveillance in Morocco.
    Elharti E; Zidouh A; Mengad R; Bennani O; Elaouad R
    East Mediterr Health J; 2002 Jan; 8(1):141-9. PubMed ID: 15330569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of HIV-1 prevalence and risk factors between pregnant, non-pregnant, all women and the general population in Tanzania: implications for second-generation surveillance.
    Mmbaga EJ; Leyna GH; Mnyika KS; Klepp KI
    Int J STD AIDS; 2009 Jul; 20(7):483-8. PubMed ID: 19541891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The feasibility of voluntary counselling and HIV testing for pregnant women using community volunteers in Zimbabwe.
    Shetty AK; Mhazo M; Moyo S; von Lieven A; Mateta P; Katzenstein DA; Maldonado Y; Hill D; Bassett MT
    Int J STD AIDS; 2005 Nov; 16(11):755-9. PubMed ID: 16303072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An assessment of mother-to-child HIV transmission prevention in 16 pilot antenatal clinics in Jamaica.
    Harvey KM; Figueroa JP; Tomlinson J; Gebre Y; Forbes S; Toyloy T; Thompson T; Thompson K
    West Indian Med J; 2004 Oct; 53(5):293-6. PubMed ID: 15675493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Attitudes to HIV and HIV testing in high prevalence areas of China: informing the introduction of voluntary counselling and testing programmes.
    Hesketh T; Duo L; Li H; Tomkins AM
    Sex Transm Infect; 2005 Apr; 81(2):108-12. PubMed ID: 15800085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV seroprevalence surveys in Nigerien pregnant women: a comparison between 2002 and 2006.
    Tohon Z; Mamadou S; Mainassara HB; Boukary RM; Lagare A; Ali Maazou AR; Izamne M; Chanteau S
    Trans R Soc Trop Med Hyg; 2007 Nov; 101(11):1101-5. PubMed ID: 17662323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Results of screening for HIV antibodies in pregnant women, clients of infertility clinics and abortion clinics in the Amsterdam region in 1990].
    Bindels PJ
    Ned Tijdschr Geneeskd; 1991 Nov; 135(45):2123-8. PubMed ID: 1944689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antenatal screening for HIV; are those who refuse testing at higher risk than those who accept testing?
    Boxall EH; Smith N
    J Public Health (Oxf); 2004 Sep; 26(3):285-7. PubMed ID: 15454598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV seropositive in pregnant South African women who initially refuse routine antenatal HIV screening.
    Mseleku M; Smith TH; Guidozzi F
    BJOG; 2005 Mar; 112(3):370-1. PubMed ID: 15713157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Who is at high risk? A comparison of the seroprevalence of human immunodeficiency virus in pregnant women and a high risk group.
    Wynter SH; Rattray C; Frederick J; Thesiger C; Wynter HH; Lindo J; McGilchrist A; King SD
    West Indian Med J; 2003 Dec; 52(4):293-5. PubMed ID: 15040065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Introduction of routine HIV testing in prenatal care--Botswana, 2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Nov; 53(46):1083-6. PubMed ID: 15565017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Refusal of prenatal HIV-testing: a case study in Abidjan (Côte d'Ivoire)].
    Desgrées du Loû A; Brou H; Djohan G; Tijou-Traoré A;
    Sante; 2007; 17(3):133-41. PubMed ID: 18180214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prevalence of HIV antibodies in pregnant women in the Amsterdam HIV reference station research, 1988-1993].
    Bindels PJ; Mulder-Folkerts DK; Schutte MF; Wong FJ; Smit I; Boer K
    Ned Tijdschr Geneeskd; 1995 May; 139(19):994-7. PubMed ID: 7753240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Post-abortion care and voluntary HIV counselling and testing--an example of integrating HIV prevention into reproductive health services.
    Rasch V; Yambesi F; Massawe S
    Trop Med Int Health; 2006 May; 11(5):697-704. PubMed ID: 16640622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Seroprevalence of HIV infection in pregnant women in the Annaba region (Algeria)].
    Aidaoui M; Bouzbid S; Laouar M
    Rev Epidemiol Sante Publique; 2008 Aug; 56(4):261-6. PubMed ID: 18687541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence of a substantial decline in prevalence of HIV-1 infection among pregnant women: data from 1995 to 2003 in Dar es Salaam, Tanzania.
    Urassa W; Kaaya S; Mwakagile D; O'Brien M; Antelman G; Hunter D; Fawzi W; Msamanga G
    Scand J Public Health; 2006; 34(3):272-8. PubMed ID: 16754585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Less refusal to participate in HIV screening among pregnant women in the Amsterdam region since the introduction of standard HIV screening using the opting-out method].
    Mulder-Folkerts DK; van den Hoek JA; van der Bij AK; Boer K; Schutte MF; Coutinho RA
    Ned Tijdschr Geneeskd; 2004 Oct; 148(41):2035-7. PubMed ID: 15554003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. From prenatal HIV testing of the mother to prevention of sexual HIV transmission within the couple.
    Desgrées-du-Loû A; Brou H; Traore AT; Djohan G; Becquet R; Leroy V
    Soc Sci Med; 2009 Sep; 69(6):892-9. PubMed ID: 19552991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Provider-initiated HIV testing and counseling in health facilities--what does this mean for the health and human rights of pregnant women?
    Gruskin S; Ahmed S; Ferguson L
    Dev World Bioeth; 2008 Apr; 8(1):23-32. PubMed ID: 18315722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What are the barriers to offering HIV testing in an antenatal setting? A national study of obstetricians.
    Giles ML; Garland SM; Lewin SR; Hellard ME
    AIDS; 2007 Jul; 21(12):1601-6. PubMed ID: 17630555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.